P

ProBioGen AG Tech Stack

Contract biopharmaceutical manufacturing and cell line development for proteins, antibodies, and viral vectors

Biotechnology Research Berlin 201–500 employees Founded 1994 Public Company

ProBioGen operates three GMP manufacturing lines in Berlin with 300+ employees focused on contract development and manufacturing for therapeutics. The hiring mix—dominated by manufacturing and research roles with mid-level technical depth—reflects active capacity expansion. Current project portfolio centers on process transfer, GMP facility construction, and scaling bioreactor workflows; alongside tech-stack adoption of cloud platforms (Azure, AWS, GCP) and infrastructure-as-code tooling (Terraform, Ansible), this signals modernization of legacy compliance and documentation systems.

Tech Stack 22 technologies

Core StackAWS Cisco Fortinet Terraform Ansible Python Grafana Prometheus CloudWatch SAP JMP PowerPoint Microsoft Office Azure GCP Aruba PowerShell Excel Outlook Teams SharePoint BIM

What ProBioGen AG Is Building

◆Challenges

Ensuring security compliance
Process transfer from development to production
Quality system development
Gmp compliant documentation
Gmp compliance during construction
Scaling up bioreactor processes to gmp
Transferring processes to lab scale
Establishing mammalian cell culture processes
Compliance monitoring
Migrating legacy workloads to cloud

▲Active Projects

Transfer to lab scale
Process transfer from development to production
Gmp facility construction and implementation
Tech-transfer to gmp production
Development of cho fed-batch processes in small scale
Handover to gmp production
Gmp-compliant production projects
Sop development
Compliance activity management
Neu- und umbau von laboren und produktionsanlagen

Hiring Activity

Steady30 roles · 10 in 30d

Department

Manufacturing

16

Research

5

Engineering

4

Ops

2

Construction

1

HR

1

Quality

1

Seniority

Mid

14

Junior

6

Intern

5

Senior

3

Director

2

Company intelligence

Find more companies like ProBioGen AG by tech stack, pain points and active projects

Get started free

About ProBioGen AG

ProBioGen is a public contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services: cell line development, process development, GMP manufacturing, and analytical testing for proteins, antibodies, viral vectors, and vaccines. Founded in 1994 as a Charité spin-off, the company operates three manufacturing facilities in Berlin and holds proprietary technologies including AGE1® producer cell lines, DirectedLuck® transposase, and GlymaxX® afucosylation. Client base spans biotech companies requiring outsourced manufacturing capacity and regulatory pathway support.

HeadquartersBerlin

Company Size201–500 employees

Founded1994

Hiring MarketsGermany

Frequently Asked Questions

What services does ProBioGen offer?

Cell line development, process development, GMP and non-GMP manufacturing, analytical assays for proteins and antibodies, viral vector and vaccine manufacturing, and technology licensing (AGE1® cell lines, DirectedLuck® transposase, GlymaxX® afucosylation).

What tech stack does ProBioGen use?

Microsoft ecosystem (Office, Teams, SharePoint), cloud platforms (Azure, AWS, GCP), infrastructure tooling (Terraform, Ansible, PowerShell), monitoring (Grafana, Prometheus, CloudWatch), and enterprise systems (SAP, JMP). No announced recent tech replacements.